Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder. Pittock SJ, Barnett M, Bennett JL, Berthele A, et al. Ann Neurol 2023;93:1053-1068.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pittock SJ, Barnett M, Bennett JL, Berthele A, et al. Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder. Ann Neurol 2023;93:1053-1068.
PMID: 36866852